Versions Compared

Old Version 6

changes.mady.by.user Diane Corey

Saved on

compared with

New Version Current

changes.mady.by.user Steve Kopko

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Completed by:Steve Kopko
Date Completed:

Name and Version of Project:
  •  Symptoms of Major Depressive Disorder Scale Version 1.0 (SMDDS v1.0)

...

  •  All internal review comments have been resolved and updated in JIRA.
  •  Supplement has been through copy-editing.
  •  The FDA priority list has been checked to see if the supplement is marked "yes". Not an FDA QRS priority.
    •  If the supplement is an FDA priority, it has gone through FDA review and additional copy-editing if there were extensive changes.
  •  Notify the SDS QRS Subteam that the supplements are ready for public review.
  •  Announcement has been prepared.
  •  Project Manager/Team Lead notified Ann White (Communications) at least 5 days before planned public review posting so she can review the announcement and post to the CDISC website.

...

  •  All public review comments have been resolved in JIRA.  If not, note above, do not put a check by the supplement name, and do not send on for the publication (will need to complete a separate public review checklist).
    •  Once all IR and PR comments are approved, mark them as "Done", export to Excel, and archive on the supplement archive page.
  •  Information boxes have been removed from supplement.
  •  All text is black except for links (which are blue). 
    •  CRF needs to be renamed to remove "Flattened".
  •  DRAFT or REVISION DRAFT has been changed to FINAL in document metadata.
  •  Revision History date and status has been updated.
  •  Supplement has been through final copy-editing step.
  •  WORD file of the supplement for publishing as a PDF has been reviewed
  •  The FDA priority list has been checked to see if the supplement is marked "yes". Not  Not an FDA QRS Priority.
    •  If the supplement is an FDA priority, it has gone through FDA quick review and additional copy-editing if there were extensive changes. Not on FDA QRS priority list, but is a FDA COA instrument that they want to review.
  •  Notify the SDS QRS Subteam that the supplements are ready for the publication stage.
  •  Announcement has been prepared.
  •  Project Manager/Team Lead notified Alana and Ann White (Communications) at least 5 days before planned posting to prepare for publication and posting to the CDISC website.